The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, ...
In-situ multiomics is revolutionizing research in oncology, immunology and neurobiology. However, speed and throughput are major bottlenecks for these critical studies. Here, we present data from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results